These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8066661)
1. Cyclosporine or rejection enhance secretion of von Willebrand factor in renal transplantation. Yussim A; Boksenboim G; Ben-Bassat M; Shmueli D; Lustig S; Bar Nathan N; Shaharabani E; Nakache R; Or H; Shapira Z Transplant Proc; 1994 Aug; 26(4):2032-3. PubMed ID: 8066661 [No Abstract] [Full Text] [Related]
2. Analysis of 214 percutaneous renal allograft biopsies. Kim HC; Park SB; Lee SH; Cho WH; Park CH; Park KK Transplant Proc; 1994 Aug; 26(4):1997-8. PubMed ID: 8066648 [No Abstract] [Full Text] [Related]
3. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection. Marcussen N; Lai R; Olsen TS; Solez K Transplant Proc; 1996 Feb; 28(1):470-6. PubMed ID: 8644316 [No Abstract] [Full Text] [Related]
4. Expression of adhesion molecules in allograft renal dysfunction: a distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity. Mampaso F; Marcen R; Molina A; Pascual J; Martin A; Bricio T Transplant Proc; 1994 Oct; 26(5):2859-60. PubMed ID: 7524222 [No Abstract] [Full Text] [Related]
5. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis. Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334 [No Abstract] [Full Text] [Related]
7. Risks and benefits of graft biopsy in renal transplantation under cyclosporin-A. Kiss D; Landmann J; Mihatsch M; Huser B; Brunner FP; Thiel G Clin Nephrol; 1992 Sep; 38(3):132-4. PubMed ID: 1395164 [TBL] [Abstract][Full Text] [Related]
8. The use of immunocytochemistry (LCA and LEU-7) in diagnosis of renal allograft rejection. Gibson IW; Marcussen N; Brown RW; Solez K; Truong LD Transplant Proc; 1996 Feb; 28(1):457-64. PubMed ID: 8644313 [No Abstract] [Full Text] [Related]
9. Serum C-reactive protein: a useful, economical marker of immune activation in cadaveric renal transplantation. Harris KR; Digard NJ; Slapak M; Lee HA Transplant Proc; 1995 Feb; 27(1):1046-7. PubMed ID: 7878797 [No Abstract] [Full Text] [Related]
10. Evaluation of fine-needle aspiration biopsy in the diagnosis of acute renal transplant dysfunction. Gonçalves LF; Manfro R; Rauber L; Edelweiss M; Prompt C Transplant Proc; 1992 Dec; 24(6):3083-4. PubMed ID: 1466065 [No Abstract] [Full Text] [Related]
11. Apoptosis in acute tubular necrosis and acute renal allograft rejection. Matsuno T; Nakagawa K; Sasaki H; Ishine N; Inagaki M; Yagi T; Haisa M; Tanaka N; Sakagami K; Orita K Transplant Proc; 1994 Aug; 26(4):2170-3. PubMed ID: 8066712 [No Abstract] [Full Text] [Related]
12. Protocol biopsy program after renal transplantation: structure and first results. Schwarz A; Mengel M; Gwinner W; Eisenberger U; Hiss M; Radermacher J; Fiebeler A; Abou-Rebyeh F; Haller H Transplant Proc; 2002 Sep; 34(6):2238-9. PubMed ID: 12270381 [No Abstract] [Full Text] [Related]
13. Fine-needle aspiration-biopsy (FNAB) in immediate post-operative period of transplant. A valid support to discriminate acute rejection vs acute tubular necrosis. Leone G; Puliatti C; Morale W; Alo PL; Di Tondo U; Leone F Clin Nephrol; 1995 Aug; 44(2):139-40. PubMed ID: 8529311 [No Abstract] [Full Text] [Related]
14. Results of a small series of renal graft biopsies in a Lebanese population. Meguerian-Bedoyan Z; Aftimos G Transplant Proc; 2001 Aug; 33(5):2678-9. PubMed ID: 11498120 [No Abstract] [Full Text] [Related]
15. Routine early biopsy of allografts with delayed function: correlation of histopathology and transplant outcome. Gaber LW; Gaber AO; Hathaway DK; Vera SR; Shokouh-Amiri MH Clin Transplant; 1996 Dec; 10(6 Pt 2):629-34. PubMed ID: 8996756 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection. Yoshimura R; Watanabe Y; Kasai S; Wada S; Ohyama A; Hase T; Nakatani T; Chargui J; Touraine JL; Nakamura T Transpl Int; 2002 Apr; 15(4):156-62. PubMed ID: 11976737 [TBL] [Abstract][Full Text] [Related]
18. Delayed use of OKT3 for severe acute tubular necrosis in renal transplantation. VanderWerf BA Transplant Proc; 1996 Aug; 28(4):2115-6. PubMed ID: 8769172 [No Abstract] [Full Text] [Related]
19. Urinary HLA-DR and CD54 expression--indicators for inflammatory activity in decoy cell shedding patients. Kim SH; Ahn HJ; Kim YS; Kim SI; Kim HS; Jeong HJ Nephrol Dial Transplant; 2006 Sep; 21(9):2601-6. PubMed ID: 16837510 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker. Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]